The Nexus Between IP And Clinical Trials: An Australian Perspective

Published date25 October 2021
Subject MatterIntellectual Property, Litigation, Mediation & Arbitration, Food, Drugs, Healthcare, Life Sciences, Patent, Trials & Appeals & Compensation, Biotechnology & Nanotechnology
Law FirmDavies Collison Cave
AuthorDr. Claire Gregg and Alex Tzanidis
    • This document is available in original version only for vLex customers

      View this document and try vLex for 7 days
    • TRY VLEX

VLEX uses login cookies to provide you with a better browsing experience. If you click on 'Accept' or continue browsing this site we consider that you accept our cookie policy. ACCEPT